RFP | April 22, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health announces the availability of funding for implementation of the National Cooperative Drug Discovery/Development Groups for the Treatment of Mental Disorders, Drug, or Alcohol Addiction (U01) Grant. The purpose of this grant is to advance the discovery, pre-clinical development, and proof of concept testing of new, rationally-based candidate agents to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Contractors should refer to Section VII . . .